Retatrutide Canada: Comprehensive Guide to the GLP-1/GIP/Glucagon Triple Agonist
Retatrutide represents the new generation of research metabolic peptides. Unlike Semaglutide (a single GLP-1 agonist) or Tirzepatide (a dual GLP-1/GIP agonist), Retatrutide simultaneously targets three distinct receptors: GLP-1, GIP, and Glucagon. This triple action makes it one of the most studied peptides currently in the field of metabolic research.
Table of Contents
Sequence: 39 modified amino acid peptide | Targets: GLP-1R, GIPR, GcgR | Half-life: ~6 days | Form: Lyophilized powder
What is Retatrutide?
Retatrutide (research code LY3437943) is a synthetic peptide developed as a triple agonist of GLP-1, GIP, and Glucagon receptors. It is a 39-amino acid molecule conjugated to a C20 fatty acid, allowing for binding to serum albumin—which explains its long half-life of approximately 6 days.
Retatrutide was designed to overcome the limitations of first and second-generation GLP-1 agonists by simultaneously activating three hormonal axes involved in metabolic regulation. This “triple agonism” approach represents a significant advancement in understanding metabolic signaling pathways.
Triple Agonist Mechanism of Action
1. GLP-1 Agonism (Glucagon-Like Peptide-1)
Activation of GLP-1 receptors modulates glucose-dependent insulin secretion, slows gastric emptying, and transmits satiety signals to the central nervous system via the hypothalamus. This mechanism is shared with Semaglutide and Tirzepatide.
2. GIP Agonism (Glucose-dependent Insulinotropic Polypeptide)
GIP is an incretin produced in the small intestine that potentiates the insulin response. GIPR receptors are also expressed in adipose tissue, the brain, and bones. Retatrutide’s activation of GIPR creates a metabolic synergy with the GLP-1 pathway—a mechanism identical to Tirzepatide in this regard.
3. Glucagon Agonism (unique to Retatrutide)
This is the third pathway that fundamentally differentiates Retatrutide. Activation of glucagon receptors (GcgR) stimulates hepatic lipolysis, increases basal energy expenditure via mitochondria, and promotes ketogenesis. Under normal conditions, glucagon is hyperglycemic—but combined with GLP-1/GIP activation, this effect is counterbalanced, allowing for beneficial metabolic effects on thermogenesis.
Retatrutide Research Areas
Metabolic Research
Preclinical studies and Phase I/II trials published in the New England Journal of Medicine (2023) have positioned Retatrutide as one of the most active peptides ever studied in the field of energy metabolism. Researchers are particularly interested in its action on brown adipose tissue and adaptive thermogenesis.
Fatty Liver Disease (NAFLD/NASH)
Retatrutide’s activation of glucagon receptors stimulates fatty acid β-oxidation in hepatocytes, making this peptide a major subject of interest in research on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Cardiovascular Research
The expression of GLP-1 and GIP receptors in the myocardium and endothelial cells opens avenues for research into the potential cardioprotective effects of triple agonists. Preclinical studies are examining the impact on cardiac function and lipid profiles.
Retatrutide vs. Tirzepatide vs. Semaglutide
To understand Retatrutide’s unique position in the landscape of metabolic research peptides, here is a comparative table of the three molecules:
| Characteristic | Retatrutide | Tirzepatide | Semaglutide |
|---|---|---|---|
| Targeted Receptors | GLP-1 + GIP + Glucagon | GLP-1 + GIP | GLP-1 only |
| Generation | Triple Agonist | Dual Agonist | Single Agonist |
| Half-life | ~6 days | ~5 days | ~7 days |
| Thermogenesis Action | ✅ Strong (via GcgR) | ⚠️ Moderate | ❌ Weak |
| Available at Peptivia Lab | 5mg / 10mg | 5mg / 10mg | 5mg / 10mg |
Retatrutide Reconstitution and Storage
Retatrutide is supplied as a lyophilized powder. For laboratory reconstitution, use bacteriostatic water (0.9% benzyl alcohol) available from Peptivia Lab.
- Inject water gently along the vial wall
- Do not shake — swirl gently
- Store in the refrigerator between 2°C and 8°C
- Reconstituted solution: use within 20-30 days
- Unreconstituted powder: store away from light
Buy Retatrutide Canada — Peptivia Lab
At Peptivia Lab, we offer laboratory-grade Retatrutide in 5 mg and 10 mg formats, shipped from Quebec with a Certificate of Analysis (COA) for each batch.
- Fast shipping 24-48h across Canada
- Certificate of Analysis (COA) included
- Customer service in French
- Bacteriostatic water available for reconstitution
→ View Retatrutide at Peptivia Lab
Frequently Asked Questions about Retatrutide Canada
Is Retatrutide legal in Canada?
Retatrutide is sold in Canada exclusively as a research peptide for scientific use. It is not approved by Health Canada for human consumption. Peptivia Lab sells its products strictly for laboratory research.
What is the difference between Retatrutide and Tirzepatide?
Tirzepatide is a dual agonist (GLP-1 + GIP) while Retatrutide is a triple agonist that adds glucagon receptor activation. This third pathway gives Retatrutide additional thermogenic action studied in energy metabolism research.
Retatrutide Phase II Study NEJM 2023
Wikipedia retatrutide